Table 3
Risk stratification for discontinuation of clopidogrel
High risk
Low risk
Drug eluting coronary artery stents within 12 months of placement
Ischaemic heart disease without coronary stents
Bare metal coronary artery stents within 1 month of placement
Cerebrovascular disease
Peripheral vascular disease